XNAS 29 Sep, 2025 4:15 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Simrat Randhawa | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2025 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Ryan Savitz | CFO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2025 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Ryan Savitz | CFO & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.44 per share. | 09 Sep 2025 | 20,000 | 20,000 | - | 8.4 | 168,800 | Common Stock |
| Ryan Savitz | CFO & CBO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 09 Sep 2025 | 20,000 | 0 | - | 35 | 700,000 | Common Stock |
| Ryan Savitz | CFO & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2025 | 20,000 | 104,766 | - | - | Stock Option (Right to Buy) | |
| Steven Joseph Romano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Jonathan Violin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Alison F. Lawton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Simon Read | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Sujay R. Kango | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Simrat Randhawa | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Ryan Savitz | CFO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Adam M. Veness | SVP, General Counsel and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Marino Garcia | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 340,000 | 340,000 | - | - | Stock Option (Right to Buy) | |
| Edward G. Carr | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Steven Joseph Romano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Marino Garcia | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 243,000 | 243,000 | - | - | Stock Option (Right to Buy) | |
| Leon O. Moulder | Director | 23 May 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | ||
| Alison F. Lawton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Paula Soteropoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Adam M. Veness | SVP, General Counsel and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Simrat Randhawa | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Ryan Savitz | CFO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Edward G. Carr | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Jonathan Violin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| Adam M. Veness | SVP, General Counsel and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Marino Garcia | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Simrat Randhawa | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Ryan Savitz | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Edward G. Carr | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Lei Meng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 1,833,333 | 1,833,333 | - | - | Pre-Funded Warrants (Right to Buy) | |
| Lei Meng | Director | Grant, award, or other acquisition of securities at price $ 12.00 per share. | 22 Jan 2024 | 1,500,000 | 2,717,554 | - | 12 | 18,000,000 | Common Stock |
| Leon O. Moulder | Director | 22 Jan 2024 | 166,667 | 1,436,745 | - | 12 | 2,000,004 | Common Stock |